European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2024
European Journal of Cancer · 2025-01 · 215 · 115153
DOI: 10.1016/j.ejca.2024.115153 ↗Kurz gefasst
Leitlinie in der Zeitschrift European Journal of Cancer, 2025-01. Verfasst von Claus Garbe und 33 weiteren Autor:innen. Beteiligte Einrichtung: Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. Electronic address: claus.garbe@med.uni-tuebing…. Hauptthemen laut MEDLINE: Consensus, Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AbbVie, Roche, Eisai.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. Electronic address: claus.garbe@med.uni-tuebingen.de.
- Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
- Institute of Dermatology, Università Cattolica, Rome, and Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.
- Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
- Department of Dermatovenereology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
- Université Paris Cite, AP-HP department of Dermatology INSERM U 976 Hôpital Saint Louis, Paris, France.
Förderung
- AbbVie
- Roche
- Eisai
- Genesis Pharma
Zitieren
APA
Garbe, C., Amaral, T., Peris, K., Hauschild, A., Arenberger, P., Basset-Seguin, N., Bastholt, L., Bataille, V., Brochez, L., Del Marmol, V., Dréno, B., Eggermont, A. M. M., Fargnoli, M. C., Forsea, A. M., Höller, C., Kaufmann, R., Kelleners-Smeets, N., Lallas, A., Lebbé, C., …, & European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF), and the European Organization for Research and Treatment of Cancer (EORT… (2025). European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2024. European Journal of Cancer, 215, 115153. https://doi.org/10.1016/j.ejca.2024.115153
Vancouver
Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2024. European Journal of Cancer. 2025;215:115153. doi:10.1016/j.ejca.2024.115153
BibTeX
@article{Garbe2025,
author = {Garbe, Claus and Amaral, Teresa and Peris, Ketty and Hauschild, Axel and Arenberger, Petr and Basset-Seguin, Nicole and Bastholt, Lars and Bataille, Veronique and Brochez, Lieve and Del Marmol, Veronique and Dréno, Brigitte and Eggermont, Alexander M M and Fargnoli, Maria Concetta and Forsea, Ana-Maria and Höller, Christoph and Kaufmann, Roland and Kelleners-Smeets, Nicole and Lallas, Aimilios and Lebbé, Celeste and Leiter, Ulrike and Longo, Caterina and Malvehy, Josep and Moreno-Ramirez, David and Nathan, Paul and Pellacani, Giovanni and Saiag, Philippe and Stockfleth, Eggert and Stratigos, Alexander J and Van Akkooi, Alexander C J and Vieira, Ricardo and Zalaudek, Iris and Lorigan, Paul and Mandala, Mario and European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF), and the European Organization for Research and Treatment of Cancer (EORT…, European Association of Dermato-Oncology (EADO), the European Dermatology Forum (EDF), and the European Organization for Research and Treatment of Cancer (EORT…},
title = {European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2024},
journal = {European Journal of Cancer},
year = {2025},
volume = {215},
pages = {115153},
doi = {10.1016/j.ejca.2024.115153}
}
EUVIMED